You are here: Home » Current Affairs » News » National
Delhi logs 2,031 new Covid cases, 9 deaths; positivity rate at 12.34%
Business Standard

Eight firms express interest in developing monkeypox vaccine to ICMR

ICMR has received 31 bids from manufacturers showing interest in developing vaccine and diagnostic kits against the monkeypox virus after the medical body floated the Expression of Interest (EOI)

Topics
ICMR | Vaccine | health care

IANS  |  New Delhi 



monkeypox
Illustration: Reuters

The Indian Council of Medical Research (ICMR) has received 31 bids from manufacturers showing interest in developing against the monkeypox virus after the medical body floated the Expression of Interest (EOI) for the development of and diagnostic kits, a source said on Saturday.

According to the source, of the total 31 bids, eight companies have submitted the EOI for the development while 23 firms showed interest towards the development of kits.

However, no company has been awarded the tender yet and it is currently under evaluation, the source added. The manufacturers would develop the vaccine through public-private partnership.

The had invited the EOI for the development of vaccine and diagnostic kits for monkeypox last month on July 27.

The EOI was invited from the experienced vaccine manufacturers, in-vitro diagnostic (IVD) kit manufacturers for joint collaboration in developing of vaccine candidate against monkeypox. The last date for submission of EOI was August 10.

Meanwhile, the capital on Saturday reported one more monkeypox infection, taking the case tally to 5. Of the five infected patients, one has been discharged and four are being treated at LNJP Hospital.

So far, India has reported 10 cases of monkeypox infection.

--IANS

avr/pgh

 

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

Dear Reader,

Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.


We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

First Published: Sun, August 14 2022. 06:49 IST

.